Kestra Medical Technologies (NASDAQ:KMTS) Insider Brian Daniel Webster Sells 15,000 Shares of Company Stock

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) insider Brian Webster sold 15,000 shares of Kestra Medical Technologies stock in a transaction on Tuesday, October 20th. The stock was sold at an average price of $29.56, for a total value of $443,400.00. Following the sale, the insider owned 445,215 shares of the company’s stock, valued at approximately $13,160,555.40. This trade represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Brian Daniel Webster also recently made the following trade(s):

• On Monday, August 17th, Brian Webster sold 15,000 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $27.48, for a total transaction of $412,200.00.
• On Tuesday, August 4th, Brian Webster sold 51,900 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $24.52, for a total transaction of $1,272,588.00.
• On Monday, August 3rd, Brian Webster sold 13,017 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $23.92, for a total transaction of $311,366.64.
• On Friday, July 31st, Brian Webster sold 8,948 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $22.60, for a total transaction of $202,224.80.
• On Thursday, July 30th, Brian Webster sold 7,857 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $22.72, for a total transaction of $178,511.04.

Kestra Medical Technologies Price Performance

Kestra Medical Technologies stock opened at $28.32 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 4.69 and a quick ratio of 4.69. The firm has a 50-day moving average of $26.42 and a two-hundred day moving average of $23.79. Kestra Medical Technologies, Ltd. has a 1 year low of $17.34 and a 1 year high of $30.00.

Kestra Medical Technologies (NASDAQ:KMTS) last issued its earnings results on Monday, September 14th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.61) by ($0.14). The company had revenue of $30.97 million during the quarter. Kestra Medical Technologies had a negative return on equity of 63.83% and a negative net margin of 140.43%. Equities analysts anticipate that Kestra Medical Technologies, Ltd. will post -2.45 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Weiss Ratings raised Kestra Medical Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, September 16th. Royal Bank Of Canada set a $30.00 target price on Kestra Medical Technologies in a research report on Tuesday, September 15th. Evercore initiated coverage on Kestra Medical Technologies in a research report on Tuesday. They set an “outperform” rating and a $34.00 target price for the company. JPMorgan Chase & Co. started coverage on Kestra Medical Technologies in a report on Monday, August 10th. They issued an “overweight” rating and a $30.00 target price for the company. Finally, BTIG Research reissued a “buy” rating and set a $32.00 price target on shares of Kestra Medical Technologies in a research report on Tuesday, September 15th. Five equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $29.00.

Institutional Investors Weigh In On Kestra Medical Technologies

Several hedge funds have recently modified their holdings of KMTS. Corient Private Wealth LP boosted its stake in shares of Kestra Medical Technologies by 284.2% during the second quarter. Corient Private Wealth LP now owns 60,614 shares of the company’s stock valued at $1,542,000 after purchasing an additional 44,839 shares in the last quarter. Sei Investments Co. increased its holdings in Kestra Medical Technologies by 22.6% during the first quarter. Sei Investments Co. now owns 237,116 shares of the company’s stock valued at $4,726,000 after buying an additional 43,753 shares during the period. Spartan Wealth Advisory Services LLC purchased a new position in Kestra Medical Technologies during the first quarter valued at approximately $603,000. Quantinno Capital Management LP purchased a new position in Kestra Medical Technologies during the first quarter valued at approximately $431,000. Finally, Bank of New York Mellon Corp raised its stake in Kestra Medical Technologies by 47.2% in the first quarter. Bank of New York Mellon Corp now owns 70,113 shares of the company’s stock worth $1,397,000 after buying an additional 22,471 shares in the last quarter.

About Kestra Medical Technologies

Kestra Medical Technologies, Inc is a medical technology company focused on developing and commercializing wearable solutions for patients at risk of sudden cardiac arrest. Its primary product is the ASSURE wearable cardioverter defibrillator, a wearable device designed to continuously monitor a patient’s heart rhythm and deliver a therapeutic shock when clinically necessary.

The company’s platform combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable system intended for use outside the hospital.